【港股通】信达生物(01801)跌4% 此前遭摩通减持1,553.61万股

金吾财讯09-19

金吾财讯 | 信达生物(01801)股价疲软，午后跌幅加剧，截至发稿，报42.05港元，跌4%，成交额3.57亿港元。根据香港联交所9月17日披露的文件，摩根大通(JPMorgan Chase & Co.)于9月11日以场内每股均价43.0477港元，场外每股均价42.9027港元合计售出信达生物1,553.61万股普通股股份，价值约6.69亿港元。售出后，摩根大通最新持股数目为8,780.56万股股份，好仓比例由6.33%降至5.38%。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2468176543?lang=zh_CN&edition=full","thumbnail":"https://static.szfiu.com/news/20210810/NDg0MDg1OTU1MTI3MjAzNTczNjYwMTQ3.jpg","is_english":false,"pubTime":"2024-09-19 14:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2468176543","market":"fut","top_or_hot":-1,"title":"【港股通】信达生物(01801)跌4% 此前遭摩通减持1,553.61万股","media":"金吾财讯","content":"<html><body><p>金吾财讯 | <a href=\"https://laohu8.com/S/01801\">信达生物</a>(01801)股价疲软，午后跌幅加剧，截至发稿，报42.05港元，跌4%，成交额3.57亿港元。根据香港联交所9月17日披露的文件，<a href=\"https://laohu8.com/S/JPM\">摩根大通</a>(JPMorgan Chase &amp; Co.)于9月11日以场内每股均价43.0477港元，场外每股均价42.9027港元合计售出信达生物1,553.61万股普通股股份，价值约6.69亿港元。售出后，摩根大通最新持股数目为8,780.56万股股份，好仓比例由6.33%降至5.38%。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【港股通】信达生物(01801)跌4% 此前遭摩通减持1,553.61万股</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【港股通】信达生物(01801)跌4% 此前遭摩通减持1,553.61万股\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-19 14:37 北京时间&nbsp;&nbsp;&nbsp;<a href=1944502><strong>金吾财讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>金吾财讯 | 信达生物(01801)股价疲软，午后跌幅加剧，截至发稿，报42.05港元，跌4%，成交额3.57亿港元。根据香港联交所9月17日披露的文件，摩根大通(JPMorgan Chase & Co.)于9月11日以场内每股均价43.0477港元，场外每股均价42.9027港元合计售出信达生物1,553.61万股普通股股份，价值约6.69亿港元。售出后，摩根大通最新持股数目为8,780.56...</p>\n\n<a href=\"1944502\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B3S45H60.SGD","symbol_name":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","start_time":0,"source_url":"1944502","article_id":"2468176543","we_media_id":"1086022552","thumbnails":["https://static.szfiu.com/news/20210810/NDg0MDg1OTU1MTI3MjAzNTczNjYwMTQ3.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468176543","pubTimestamp":1726727860,"sourceInfo":null,"weMediaInfo":{"media_name":"金吾财讯","introduction":"「金吾财讯」以精准用户需求为切入点，打造一站式港美股投资细分领域品牌。依托战略合作伙伴凤凰网财经，将港美股内容传播到全球华人圈。","home_visible":1,"id":"1086022552","head_image":"https://static.tigerbbs.com/19a93586c3b023ec6ebfed568990555c"},"summary":"金吾财讯 | 信达生物(01801)股价疲软，午后跌幅加剧，截至发稿，报42.05港元，跌4%，成交额3.57亿港元。根据香港联交所9月17日披露的文件，摩根大通(JPMorgan Chase & Co.)于9月11日以场内每股均价43.0477港元，场外每股均价42.9027港元合计售出信达生物1,553.61万股普通股股份，价值约6.69亿港元。售出后，摩根大通最新持股数目为8,780.56万股股份，好仓比例由6.33%降至5.38%。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00B3S45H60.SGD":"Neuberger Berman US Multicap Opportunities A Acc SGD-H","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","BK4516":"特朗普概念","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","LU0323591593.USD":"SCHRODER ISF QEP GLOBAL QUALITY \"A\" (USD) ACC","LU1119994496.HKD":"FIDELITY WORLD \"A\" (HKD) ACC","IE00BHPRN162.USD":"BNY MELLON BLOCKCHAIN INNOVATION \"B\" (USD) ACC","BK1589":"北水核心资产","YANG":"三倍做空富时中国ETF-Direxion","HSCEI":"国企指数","BK4585":"ETF&股票定投概念","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK1583":"高瓴概念","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","BK4566":"资本集团","HSTECH":"恒生科技指数","LU0310799852.SGD":"FTIF - Templeton Global Equity Income A MDIS SGD","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","01801":"信达生物","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","IE00BWXC8680.SGD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A5\" (SGD) ACC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","LU0106831901.USD":"贝莱德世界金融基金A2","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0215105999.USD":"SCHRODER ISF GLOBAL EQUITY \"A\" ACC","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","LU1032466523.USD":"高盛全球多资产收益组合Acc","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU1244550221.USD":"FRANKLIN GLOBAL MULTI-ASSET  INCOME \"A\" (USDHEDGED) INC (M)","LU1064131342.USD":"Fullerton Lux Funds - Global Absolute Alpha A Acc USD","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","07226":"XL二南方恒科","BK1161":"生物科技","LU0211327993.USD":"TEMPLETON GLOBAL EQUITY INCOME \"A\" (USD) ACC","LU1267930490.SGD":"TEMPLETON GLOBAL EQUITY INCOME \"AS\" (SGD) INC A","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","BK4504":"桥水持仓","LU":"陆金所","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU0256863811.USD":"ALLIANZ US EQUITY \"A\" INC","LU1668664300.SGD":"Blackrock World Financials A2 SGD-H","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC"},"translate_title":"[Hong Kong Stock Connect] Innovent Biologics (01801) fell 4% after JPMorgan reduced its holdings by 15.5361 million shares","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"07226":1,"YANG":1,"HSTECH":1,"HSCEI":1,"01801":1,"LU":0.6},"content_text":"金吾财讯 | 信达生物(01801)股价疲软，午后跌幅加剧，截至发稿，报42.05港元，跌4%，成交额3.57亿港元。根据香港联交所9月17日披露的文件，摩根大通(JPMorgan Chase & Co.)于9月11日以场内每股均价43.0477港元，场外每股均价42.9027港元合计售出信达生物1,553.61万股普通股股份，价值约6.69亿港元。售出后，摩根大通最新持股数目为8,780.56万股股份，好仓比例由6.33%降至5.38%。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468176543"}